Long non-coding RNA HEIH: a novel tumor activator in multiple cancers.

ABSTRACT: The last decade has witnessed the altered expression levels of long non-coding RNA HEIH in different types of cancer. More than half of the HEIH studies in cancer have been published within the last two years. To our knowledge, this is the first review to discuss very recent developments and insights into HEIH contribution to carcinogenesis. The functional role, molecular mechanism, and clinical significance of HEIH in human cancers are described in detail. The expression of HEIH is elevated in a broad spectrum of cancers, and its disorder contributes to cell proliferation, migration, invasion, and drug resistance of cancer cells through different underlying mechanisms. In addition, the high expression of HEIH is significantly associated with advanced tumor stage, tumor size and decreased

SUBMITTER: Sun JY 

PROVIDER: S-EPMC8543845 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature